For all media enquiries please email us on media@melanoma.org.au
Recordings of MPA-MIA Melanoma Community Webinar Series 2025
Watch recordings of our MPA-MIA Melanoma Community Webinar series. All three recordings are now available: Genetic testing for melanoma, Neoadjuvant immunotherapy, and a Deep dive into sunscreen.
NHMRC grants for UNCUT and Automate Me clinical trials
Prestigious National Health and Medical Research Council (NHMRC) grants have been awarded for two clinical trials aiming to improve the accuracy of skin cancer diagnosis in Australia.
MIA clinicians & researchers share latest results at ASCO25
Read more about MIA clinicians and researchers in Chicago for ASCO25 - the American Society of Clinical Oncology Annual Meeting - to share latest research and clinical trial results with international colleagues.
Our ‘bench to bedside’ research is saving lives
Read more about our world-leading 'bench to bedside' research cycle, and how you can support it this tax-time, so we can ultimately save ALL lives from melanoma.
Creative and courageous community fundraisers
We recognise our incredible community of fundraisers who continue to amaze us with their courage and creativity. From comedy nights and golf days to marathons, music gigs, Facebook fundraisers and more – they've found unique ways to make a difference.
Minimising surgery and drug intervention
Three studies led by researchers at Melanoma Institute Australia (MIA) are paving the way for less surgical and drug intervention for early stage melanoma patients.
A magical evening planned for Annual Melanoma Charity Ball
Guests at this year’s Amie St Clair Ball in Wagga Wagga will be welcomed to a ‘Night at the Carnival’ themed evening.
Raising funds and sparking life-saving conversations
Read more about the amazing initiatives organised by our wonderful community, which not only raise critical funds for research, but also generate life-saving awareness.
MIA awarded prestigious NHMRC grant
The NHMRC grant will enable MIA to lead an international clinical trial aiming to safely reduce surgery for high risk Stage III melanoma patients who have had a good response to neoadjuvant immunotherapy.
Addressing fear of cancer recurrence
A study has been released investigating the effectiveness of a Melanoma Care Program for patients with early-stage melanoma with varying degrees of fear of cancer recurrence after treatment of their primary melanoma.
Global accuracy of MIA risk tool predicting sentinel node metastasis
The extensive global use of MIA’s online tool for estimating the risk of nodal metastasis in newly diagnosed melanoma patients has prompted an international study to validate its accuracy & improve its precision across diverse populations worldwide.
Leading MIA researchers and clinicians share latest advances in Athens
MIA researchers and clinicians attended the World Congress of Melanoma, held in conjunction with the EADO Congress, in Athens.
Suzanne Sherwood says:
Steve Cole says:
Catherine Mardell says: